Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
THERAVANCE BIOPHARMA INC
Ticker: TBPH
CUSIP: G8807B106
Class: Common Stock
First Pacific Advisors, LP's Holding History (CIK: 0001377581)
Note: Option positions (PUT/CALL) are excluded.
Q2 2022
Shares
176,539
Value ($000)
$1,599
Avg Close
$9.21
Range
$8.15 - $10.52
Q1 2022
Shares
139,774
Value ($000)
$1,336
Avg Close
$9.80
Range
$7.71 - $13.17
Period
Shares
Value ($000)
Average Close
Price Range
Q2 2022
176,539
$1,599
$9.21
$8.15 - $10.52
Q1 2022
139,774
$1,336
$9.80
$7.71 - $13.17